The mechanism of effect of Growth Hormone on preadipocyte and adipocyte function

Obesity Reviews

Volumn 1, Issue 2, 2000, Pages 73-86

  Nam, S Y ^a   Lobie, P E ^b  

^a Yonsei University College of Medicine   (South Korea)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Adipocyte; Growth hormone; Lipolysis; Preadipocyte; Signal transduction

Indexed keywords

GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECT; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; HUMAN GROWTH HORMONE; HUMANS; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 0034289895     PISSN: 14677881     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1467-789x.2000.00015.x     Document Type: Review

References (180)

1. Johannsson G, Rosen T, Lonn L, Bengtsson BA. Effects of recombinant human growth hormone on adipose tissue in adults with growth hormone deficiency. Acta Paediatr Suppl December 1994; 406: 60-63.
2. Li C, Simpson ME, Evans HM. Influence of growth and adrenocorticotropic hormones on the body composition of hypohysectomized rats. Endocrinology 1949; 44: 71-75.
3. Scow R. Effect of growth hormone and thyroxine on growth and chemical composition of muscle, bone and other tissues in thyroidectomized-hypophysectomized rats. Am J Physiol 1959; 196: 859-865.
4. Oberbauer AM, Stern JS, Johnson PR, Horwitz BA, German JB, Phinney SD, Beermann DH, Pomp D, Murray JD. Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype. Growth Dev Aging 1997; 61: 169-179.
5. Wabitsch M, Hauner H, Heinze E, Teller WM. The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 1995; 44: 45-49.
6. Bonnet FP, Vanderscheuren-Lodeweyckx M, Eeckels R, Malvaux P. Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with growth hormone. Pediatr Res 1974; 8: 800-805.
7. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid Volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1993; 38: 63-71.
8. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
9. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-317.
10. Zachmann M, Fernandez F, Tassinari D, Thakker R, Prader A. Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. Eur J Pediatr 1980; 133: 277-282.
11. Brook CG. Effect of human growth hormone treatment on adipose tissue in children. Arch Dis Child Sep 1973; 48: 725-728.
12. Snyder DK, Underwood LE, Clemmons DR. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am J Clin Nutr 1990; 52: 431-437.
13. Skaggs SR, Crist DM. Exogenous human growth hormone reduces body fat in obese women. Horm Res 1991; 35: 19-24.
14. Nam SY, Marcus C. Growth hormone and adipocyte function in obesity. Horm Res 2000; 53 (51): 87-97.
15. Richelsen B. Action of growth hormone in adipose tissue. Horm Res 1997; 48: 105-110.
16. Jorgensen JO, Vahl N, Fisker S, Norrelund H, Nielsen S, Dall R, Christiansen JS. Somatopause and adiposity. Horm Res 1997; 48: 101-104.
17. Wabitsch M, Hauner H, Heinze E, Teller W. In vitro effects of growth hormone in adipose tissue. Acta Paediatr Suppl 1994; 406: 48-53.
18. Lobie PE. Signal transduction through the growth hormone receptor. In: Bengtsson BA (ed). Growth Hormone. Kluwer Academic Publishers: Boston, 1999, pp 17-35.
19. Carter-Su C, Smit LS. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Recent Prog Horm Res 1998; 53: 61-82.
20. Billestrup N, Hansen JA, Hansen LH, Moldrup AH, Galsgaard ED, Nielsen JH. Molecular mechanism of growth hormone signalling. Endocr J 1998; 45: S41-S45.
21. Fagin KD, Lackey SL, Reagan CR, DiGirolama M. Specific binding of GH by rat adipocytes. Endocrinology 1980; 107: 608-615.
22. Herington AC. Identification and characterization of growth hormone receptors on isolated rat adipocytes. J Recept Res 1981; 2: 299-316.
23. Gavin JR, Saltman RJ, Tollefsen SE. Growth hormone receptors in isolated rat adipocytes. Endocrinology 1982; 110: 637-643.
24. Gritching G, Levy LK, Goodman HM. Relationship between binding and biological effects of human growth hormone in rat adipocytes. Endocrinology 1983; 113: 1111-1120.
25. Carter-Su C, Schwartz J, Kikuchi G. Identification of high affinity growth hormone receptor in rat adipocyte membranes. J Biol Chem 1984; 259: 1099-1104.
26. LaFranchi S, Hanna CE, Torresani T, Schoenle E, Illig R. Comparison of growth hormone binding and metabolic response in rat adipocytes of epididymal, subcutaneous, and retroperitoneal origin. Acta Endocrinol Copenh 1985; 110: 50-55.
27. DiGirolamo M, Eden S, Enberg G, Isaksson O, Lonnroth P, Hallo K, Smith V. Specific binding of human GH but not IGFs by human adipocytes. FEBS Lett 1986; 205: 15-19.
28. Herington AC, Ymer S, Roupas P, Stevenson J. Growth hormone binding proteins in high speed cytosols of multiple tissues of the rabbit. Biochim Biophys Acta 1986; 881: 236-240.
29. Frick GP, Leonard JL, Goodman HM. Effect of hypophysectomy on GH receptor gene expression in rat tissues. Endocrinology 1990; 126: 3076-3082.
30. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-471.
31. Vikman K, Carlsson B, Billig H, Eden S. Expression and regulation of growth hormone (GH) receptor messenger ribonucleic acid (mRNA) in rat adipose tissue, adipocytes and adipocyte precursor cells: GH regulation of GH receptor mRNA. Endocrinology 1991; 129: 1155-1161.
32. Tiong TS, Herington AC. Tissue distribution, characterization and regulation of the mRNA for growth hormone receptor and serum binding protein in the rat. Endocrinology 1991; 129: 1628-1634.
33. Mertani HC, Delehaye-Zervas Martini JF, Postel-Vinay MC, Morel G. Localization of growth hormone receptor messenger RNA in human tissues. Endocrine 1995; 3: 135-142.
34. Mertani H, Morel G. In situ gene expression of growth hormone (GH) receptor and growth hormone binding protein in adult male rat tissues. Mol Cell Endo 1995; 109: 47-61.
35. Green H, Morikawa M, Nixon T. A dual effector theory of growth-hormone action. Differentiation 1985; 29: 195-198.
36. Wickelgren RB, Landin KL, Ohlsson C, Carlsson LM. Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner. J Clin Endocrinol Metabol 1995; 80: 2154-2157.
37. Kamel A, Margery V, Norstedt G, Thoren M, Lindgren AC, Bronnegard M, Marcus C. Growth hormone (GH) treatment up-regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader-Willi syndrome. Pediatr Res 1995; 38: 418-421.
38. Brameld JM, Atkinson JL, Saunders JC, Pell JM, Buttery PJ, Gilmour RS. Effects of growth hormone administration and dietary protein intake on insulin-like growth factor I and growth hormone receptor mRNA. Expression in porcine liver, skeletal muscle, and adipose tissue. J Anim Sci 1996; 74: 1832-1841.
39. Norstedt G, Enberg B, Francis SM, Lobie PE. The growth hormone receptor during development. Reprod Dom Anim 1993; 28: 145-153.
40. Landron D, Dugail I, Ardouin B, Quignard-Boulange A, Postel-Vinay MC. Growth hormone binding to cultured preadipocytes from obese fa/fa rats increases during cell differentiation. Horm Metab Res 1987; 19: 403-406.
41. Zou L, Menon RK, Sperling MA. Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism 1997; 46: 114-118.
42. Waters MJ. The growth hormone receptor. In: Kostyo JL, Goodman HM (ed). The Handbook of Physiology. Oxford Press: Oxford, 1999, pp 397-444.
43. Ross RJ, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PR, Postel-Vinay MC, Finidori J. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 1997; 11: 265-273.
44. Frick GP, Goodman HM. Characterization of the short isoform of the growth hormone receptor synthesized by rat adipocytes. Endocrinology 1992; 131: 3083-3090.
45. Ilkbahar YN, Wu K, Thordarson G, Talamantes F. Expression and distribution of messenger ribonucleic acids for growth hormone (GH) receptor and GH-binding protein in mice during pregnancy. Endocrinology 1995; 136: 386-392.
46. Goodman HM, Frick GP, Tai LR. The significance of the short form of the growth hormone receptor in rat adipocytes. Proc Soc Exp Biol Med 1994; 206: 304-308.
47. Gorin E, Goodman HM. Turnover of growth hormone receptors in rat adipocytes. Endocrinology 1985; 116: 1796-1805.
48. Frick GP, Tai LR, Goodman HM. Subcellular distribution of the long and short isoforms of the growth hormone (GH) receptor in rat adipocytes: both isoforms participate in specific binding of GH. Endocrinology 1994; 134: 307-314.
49. Lim L, Spencer SA, McKay P, Waters MJ. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 1990; 127: 1287-1291.
50. Bick T, Frick GP, Leonard D, Leonard JL, Goodman HM. Overexpression of the short form of the growth hormone receptor in 3T3-L1 mouse preadipocytes. Proc Soc Exp Biol Med 1994; 206: 185-189.
51. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 1998; 273: 31327-31336.
52. Zhu T, Lobie PE. JAK2 dependent activation of p38 MAP kinase by growth hormone: Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem 2000; 275: 2103-2114.
53. Argetsinger LS, Hsu GW, Myers MG, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon gamma and leukaemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 1995; 270: 14685-14692.
54. Ridderstrale M, Degerman E, Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem 1995; 279: 3471-3474.
55. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon gamma and leukaemia inhibitory factor utilize insulin receptor substrate 2 in intracellular signalling. J Biol Chem 1996; 271: 29415-29421.
56. Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 1997; 138: 4301-4307.
57. Yenush L, White MF. The IRS-signalling system during insulin and cytokine action. Bioessays 1997; 19: 491-500.
58. Yin T, Shen R, Feng GS, Yang YC. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem 1997; 272: 1032-1037.
59. Zhu T, Goh EL, LeRoith D, Lobie PE. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130 (Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 1998; 273: 33864-33875.
60. Ram PA, Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 1997; 272: 17694-17702.
61. Kim SO, Jiang J, Yi W, Feng GS, Frank SJ. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem 1998; 273: 2344-2354.
62. Gebert CA, Park SH, Waxman DJ. Termination of growth hormone pulse-induced STAT5b signaling. Mol Endocrinol 1999; 13: 38-56.
63. Ram PA, Waxman DJSOCS, /CIS. protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999; 274: 35553-35561.
64. Dekker LV, Parker PJ. Protein kinase C. a question of specificity. TIBS 1994; 19: 73-77.
65. Okada S, Kopchick JJ. Growth hormone and insulin stimulate different subsets of protein kinase C isotypes through different mechanisms. Proceedings of the 79th Ann Meet Endocrine Soc 1997; Abs: 576.
66. Doglio A, Dani C, Grimaldi P, Ailhaud G. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc Natl Acad Sci USA 1989; 86: 1148-1152.
67. Johnson RM, Napier MA, Cronin MJ, King KL. Growth hormone stimulates the formation of sn-1,2-diacylglycerol in rat heaptocytes. Endocrinology 1990; 127: 2099-2103.
68. Rogers SA, Hammerman MR. Growth hormone activates phospholipase C in proximal tubular basolateral membranes from canine kidney. Proc Natl Acad Sci USA 1989; 86: 6363-6366.
69. Roupas P, Herington AC. Signalling mechanisms involved in the production of diacylglycerol by growth hormone. Proceedings of the 77th Meet Endocrine Soc 1995; Abs: 345.
70. Argetsinger LS, Carter-Su C. Mechanism of signalling by growth hormone receptor. Physiol Rev 1996; 76: 1089-1107.
71. MacKenzie S, Fleming I, Houslay MD, Anderson NG, Kilgour E. Growth hormone and phorbol esters require specific protein kinase C isoforms to activate mitogen-activated protein kinases in 3T3-F442A cells. Biochem J 1997; 324: 159-165.
72. Kilgour E, Gout I, Anderson NG. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways. Biochem J 1996; 315: 517-522.
73. Gaur S, Yamaguchi H, Goodman HM. Growth hormone increases calcium uptake in rat fat cells by a mechanism dependent on protein kinase C. Am J Physiol 1996; 270: C1485-C1492.
74. Ilondo MM, DeMeyts P, Bouchelouche P. Human growth hormone increases cytosolic free calcium in cultured human IM-9 lymphocytes: a novel mechanism mechanism of growth hormone transmembrane signalling. Biochem Biophys Res Communic 1994; 202: 391-397.
75. Schwartz Y, Goodman HM. Refractoriness to the insulin like effects of growth hormone depends upon calcium. Endocrinology 1990; 126: 170-176.
76. Schwartz Y, Yamaguchi H, Goodman HM. Growth hormone increases intracellular free calcium in rat adipocytes: correlations with actions on carbohydrate metabolism. Endocrinology 1992; 131: 772-778.
77. Billestrup N, Bouchelouche P, Allevato G, Ilondo M, Nielsen JH. Growth hormone receptor C-terminal domains required for growth hormone-induced intracellular free calcium oscillations and gene transcription. Proc Natl Acad Sci USA 1995; 92: 2725-2729.
78. Morikawa M, Nixon T, Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell 1982; 29: 783-789.
79. Nixon T, Green H. Contribution of growth hormone to the adipogenic activity of serum. Endocrinology 1984; 114: 527-532.
80. Hauner H, Loffler G. Adipogenic factors in human serum promote the adipose conversion of 3T3-L1 fibroblasts. Int J Obes 1986; 10: 323-330.
81. Doglio A, Dani C, Grimaldi P, Ailhaud G. Growth hormone regulation of the expression of differentiation-dependent genes in preadipocyte Ob1771 cells. Biochem J 1986; 238: 123-129.
82. Deslex S, Negrel R, Ailhaud G. Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res 1987; 168: 15-30.
83. Vassaux G, Negrel R, Ailhaud G, Gaillard D. Proliferation and differentiation of rat adipose precursor cells in chemically defined medium: differential action of anti-adipogenic agents. J Cell Physiol 1994; 161: 249-256.
84. Hauner H, Loffler G. Adipose tissue development: the role of precursor cells and adipogenic factors. Part I. Adipose tissue development and the role of precursor cells. Klin Wochenschr 1987; 65: 803-811.
85. Loffler G, Hauner H. Adipose tissue development: the role of precursor cells and adipogenic factors. Part II. The regulation of the adipogenic conversion by hormones and serum factors. Klin Wochenschr Sep 1987; 65 (17): 812-817.
86. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207-233.
87. Wabitsch M, Heinze E, Hauner H, Shymko RM, Teller WM, De Meyts P, Ilondo MM. Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism 1996; 45: 34-42.
88. Kamel A, Norgren S, Eliman A, Danielsson P, Marcus C. Effect of growth hormone treatment in obese prepubertal boys. J Clin Endocrinol Metab 2000; 85: 1412-1419.
89. Wabitsch M, Braun S, Hauner H, Heinze E, Ilondo MM, Shymko R, De Meyts P, Teller WM. Mitogenic and antiadipogenic properties of human growth hormone in differentiating human adipocyte precursor cells in primary culture. Pediatr Res 1996; 40: 450-456.
90. Goodman HM. Effects of growth hormone on the penetration of L-arabinose into adipose tissue. Endocrinology 1966; 78: 819-825.
91. Carter-Su C, Rozsa FW, Wang X, Stubbart JR. Rapid and transitory stimulation of 3-O-methylglucose transport by growth hormone. Am J Physiol 1988; 255: E723-E729.
92. Honeyman TW, Goodman HM. Effects of growth hormone on glycogen metabolism in adipose tissue of hypophysectomized rats. Am J Physiol 1980; 238: E389-E394.
93. Goodman HM. In vitro effects of growth hormone on glucose metabolism in adipose tissue. Endocrinology 1965; 76: 216-220.
94. Goodman HM. The effects of growth hormone on the utilization of L-leucine in adipose tissue. Endocrinology 1978; 102: 210-217.
95. Goodman HM, Schwartz Y, Tai LR, Gorin E. Actions of growth hormone on adipose tissue: possible involvement of autocrine or paracrine factors. Acta Paediatr Scand Suppl 1990; 367: 132-136.
96. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen ER Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int Mar 1993; 52: 222-226.
97. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 1996; 137: 35-41.
98. Phelps CJ, Bartke A. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice. Endocrinology 1997; 138: 2849-2855.
99. Norstedt G, Palmiter R. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 1984; 36: 805-812.
100. Murphy WJ, Durum SK, Longo DL. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J Immunol 1992; 149: 3851-3857.
101. Ewton DZ, Florini JR. Relative effects of the somatomedins, multiplication-stimulating activity, and growth hormone on myoblasts and myotubes in culture. Endocrinology 1980; 106: 577-583.
102. Corin RE, Guller S, Wu KY, Sonenberg M. Growth hormone and adipose differentiation: growth hormone-induced anti-mitogenic state in 3T3-F442A preadipose cells. Proc Natl Acad Sci USA 1990; 87: 7507-7511.
103. Tang B, Jeoung DI, Sonenberg M. Effect of human growth hormone and insulin on [3H]thymidine incorporation, cell cycle progression, and cyclin D expression in 3T3-F442A preadipose cells. Endocrinology 1995; 136: 3062-3069.
104. Wiepz GJ, Houtman JC, Cha D, Bertics PJ. Growth hormone attenuation of epidermal growth factor-induced mitogenesis. J Cell Physiol 1999; 173: 44-53.
105. Kim SO, Houtman JC, Jiang J, Ruppert JM, Bertics PJ, Frank SJ. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem 1999; 274: 36015-36024.
106. Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 1989; 9: 4196-4203.
107. Guller S, Sonenberg M, Wu KY, Szabo P, Corin RE. Growth hormone-dependent events in the adipose differentiation of 3T3-F442A fibroblasts: modulation of macromolecular synthesis. Endocrinology 1989; 125: 2360-2367.
108. Guller S, Corin RE, Yuan-Wu K, Sonenberg M. Up regulation of vinculin expression in 3T3 preadipose cells by growth hormone. Endocrinology 1991; 129: 527-533.
109. Guller S, Allen DL, Corin Re Lockwood CJ, Sonenberg M. Growth hormone and fibronectin expression in 3T3 preadipose cells. Endocrinology 1992; 130: 2609-2616.
110. Zhu T, Goh EL, Lobie PE. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription. J Biol Chem 1998; 273: 10682-10689.
111. Ilic D, Damsky CH, Yamamoto T. Focal adhesion kinase: at the crossroads of signal transduction. J Cell Sci 1997; 110: 401-407.
112. Streuli CH, Edwards GM, Delcommenne M, Whitelaw CB, Burdon TG, Schindler C, Watson CJ. Stat5 as a target for regulation by extracellular matrix. J Biol Chem, 1995; 270: 21639-21644.
113. Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J Biol Chem 1999; 274: 8662-8668.
114. MacKenzie SJ, Yarwood SJ, Peden AH, Bolger GB, Vernon RG, Houslay MD. Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes. Proc Natl Acad Sci USA 1998; 95: 3549-3554.
115. Yarwood SJ, Kilgour E, Anderson NG. Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREB. Mol Cell Endocrinol 1998; 138: 41-50.
116. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994; 370: 223-226.
117. Gurland G, Ashcom G, Cochran BH, Schwartz J. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes. Endocrinology 1990; 127: 3187-3195.
118. Sumantran VN, Tsai ML, Schwartz J. Growth hormone induces c-fos and c-jun expression in cells with varying requirements for differentiation. Endocrinology 1992; 130: 2016-2024.
119. Clarkson RW, Chen CM, Harrison S, Wells C, Muscat GE, Waters MJ. Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta. Mol Endocrinol 1995; 9: 108-120.
120. Brun RP, Kim JB, Hu E, Altiok S, Spiegelman BM. Adipocyte differentiation: a transcriptional regulatory cascade. Curr Opin Cell Biol 1996; 8: 826-832.
121. Padines-Figueres A, Barcellini-Couget S, Dani C, Vannier C, Ailhaud G. Transcriptional control of the expression of lipoprotein lipase gene by growth hormone in preadipocyte Ob1771 cells. J Lipid Res 1990; 31: 1283-1291.
122. Amri EZ, Barbaras R, Doglio A, Dani C, Grimaldi P, Ailhaud G. Role of spermidine in the expression of late markers of adipose conversion. Effects of growth hormone. Biochem J 1986; 239: 363-370.
123. Doglio A, Dani C, Fredrikson G, Grimaldi P, Ailhaud G. Acute regulation of insulin-like growth factor-1 gene expression by growth hormone during adipose cell differentiation. EMBO J 1987; 6: 4011-4016.
124. Catalioto RM, Gaillard D, Ailhaud G, Negrel R. Terminal differentiation of mouse preadipocyte cells: the mitogenic-adipogenic role of growth hormone is mediated by the protein kinase C signalling pathway. Growth Factors 1992; 6: 255-264.
125. Negrel R, Grimaldi P, Ailhaud G. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc Natl Acad Sci USA 1978; 75: 6054-6058.
126. Green H, Kehinde OJ. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line. Cell Physiol 1979; 101: 169-171.
127. Flint DJ, Gardner MJ. Influence of growth hormone deficiency on growth and body composition in rats: site-specific effects upon adipose tissue development. J Endocrinol 1993; 137: 203-211.
128. Hansen LH, Madsen B, Teisner B, Nielsen JH, Billestrup N. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation. Mol Endocrinol 1998; 12: 1140-1149.
129. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucl Acids Res 1994; 22: 5628-5634.
130. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 1996; 274: 2100-2103.
131. Kopczynski CC, Alton AK, Fechtel K, Kooh PJ, Muskavitch MA. Delta, a Drosophila neurogenic gene, is transcriptionally complex and encodes a protein related to blood coagulation factors and epidermal growth factor of vertebrates. Genes Dev 1988; 2: 1723-1735.
132. Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993; 73: 725-734.
133. Birnbaum RS, Goodman HM. Comparison of several insulin-like effects of growth hormone. Horm Metab Res 1979; 11: 136-142.
134. Goodman HM, Frick GP. Effects of growth hormone on the oxidation of [1-14C]-pyruvate in adipose tissue of hypohysectomised rats. Horm Metab Res 1981; 13: 351-355.
135. Smal J, Closset J, Henneen G, De Meyts P. Receptor binding properties and insulin-like effects of human growth hormone and its 20 kDa-variant in rat adipocytes. J Biol Chem 1987; 262: 11071-11079.
136. Schwartz J, Carter-Su C. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: dependence on cell differentiation. Endocrinology 1988; 122: 2247-2256.
137. Moller C, Emtner M, Arner P, Norstedt G. Growth hormone regulation of lipid metabolism in cells transfected with growth hormone receptor cDNA. Mol Cell Endocrinol 1994; 99: 111-117.
138. Lobie PE, Allevato G, Nielsen JH, Norstedt G, Billestrup N. Requirement of tyrosine residues 333 and 338 of the growth hormone (GH) receptor for selected GH-stimulated function. J Biol Chem 1995; 270: 21745-21750.
139. VanderKuur JA, Wang X, Zhang L, Allevato G, Billestrup N, Carter-Su C. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J Biol Chem 1738-44; 1995: 2.
140. Smal J, De Meyts P. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. Proc Natl Acad Sci USA 1989; 86: 4705-4709.
141. Smal J, Kathuria S, De Meyts P. Acridine orange, an inhibitor of protein kinase C, abolishes insulin and growth hormone stimulation of lipogenesis in rat adipocytes. FEBS Lett 1989; 244: 465-468.
142. Ridderstrale M, Tornqvist H. Effects of tyrosine kinase inhibitors on tyrosine phosphorylations and the insulin-like effects in response to human growth hormone in isolated rat adipocytes. Endocrinology 1996; 137: 4650-4656.
143. Ridderstrale M, Tornqvist HPI. -3-kinase inhibitor Wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun 1994; 203: 306-310.
144. Lobie PE, Zhu T, Graichen R, Goh EL. Growth hormone, insulin like growth factor-1 and the central nervous system: Localization, Function and Mechanism of Action. Growth Horm IGF Res 2000; in press.
145. Eriksson H, Tornqvist H. Specific inhibition of the cGMP-inhibited cAMP phosphodiesterase blocks the insulin-like antilipolytic effect of growth hormone in rat adipocytes. Mol Cell Biochem 1997; 169: 37-42.
146. Bjorgell P, Rosberg S, Isaksson O, Belfrage P. The antilipolytic, insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation. Endocrinology 1984; 115: 1151-1156.
147. Rahn T, Ridderstrale M, Tornqvist H, Manganiello V, Fredrikson G, Belfrage P, Degerman E. Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin. FEBS Lett 1994; 350: 314-318.
148. Tanner JW, Leingang KA, Mueckler MM, Glenn KC. Cellular mechanism of the insulin-like effect of growth hormone in adipocytes. Rapid translocation of the HepG2-type and adipocyte/muscle glucose transporters. Biochem J 1992; 282, 99-106.
149. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 1999; 274: 10071-10078.
150. Berti L, Gammeltoft S. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol 1999; 157: 121-130.
151. Tai PK, Liao JF, Chen EH, Dietz J, Schwartz J, Carter-Su C. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells. J Biol Chem 1990; 265: 21828-21834.
152. Kilgour E, Baldwin SA, Flint DJ. Divergent regulation of rat adipocyte GLUT1 and GLUT4 glucose transporters by GH. J Endocrinol 1995; 145: 27-33.
153. Fain JN. Studies on the role of RNA and protein synthesis in the lipolytic action of growth hormone in isolated fat cells. Adv Enzyme Regul 1967; 5: 39-51.
154. Fain JN, Ihle JH, Bahouth SW. Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem Biophys Res Commun 1999; 263: 201-205.
155. Shimizu M, Torti F, Roth RA. Characterization of the insulin and insulin-like growth factor receptors and responsitivity of a fibroblast/adipocyte cell line before and after differentiation. Biochem Biophys Res Commun 1986; 137: 552-558.
156. Watt PW, Finley E, Cork S, Clegg RA, Vernon RG. Chronic control of the beta- and alpha 2-adrenergic systems of sheep adipose tissue by growth hormone and insulin. Biochem J 1991; 273: 39-42.
157. Beauville M, Harant I, Crampes F, Riviere D, Tauber MT, Tauber JP, Garrigues M. Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response. Am J Physiol 1992; 263: E467-E472.
158. Marcus C, Margery V, Kamel A, Bronnegard M. Effects of growth hormone on lipolysis in humans. Acta Paediatr Suppl 1994; 406: 54-58.
159. Vernon RG, Piperova L, Watt PW, Finley E, Lindsay-Watt S. Mechanisms involved in the adaptations of the adipocyte adrenergic signal-transduction system and their modulation by growth hormone during the lactation cycle in the rat. Biochem J 1993; 289: 845-851.
160. Stralfors P, Bjorgell P, Belfrage P. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc Natl Acad Sci USA 1984; 81: 3317-3321.
161. Fain JN, Saperstein R. The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids. Horm Metab Res 1970; 2: 20-27.
162. Yip RG, Goodman HM. Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions. Endocrinology 1999; 140: 1219-1227.
163. Dietz J, Schwartz J. Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes. Metabolism 1991; 40: 800-806.
164. Eisen HJ, Goodman HM. Growth hormone and phosphorylase activity in adipose tissue. Endocrinology 1969; 84: 414-416.
165. Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res 1994; 35: 1535-1541.
166. Doris RA, Kilgour E, Houslay MD, Vernon RG. Regulation of the GTP-binding protein-based antilipolytic system of sheep adipocytes by growth hormone. J Endocrinol 1998; 158: 295-303.
167. Birnbaumer L, Abramowitz J, Brown AM. Receptor-effector coupling by G proteins. Biochim Biophys Acta 1990; 1031: 163-224.
168. Houslay MD. Protein kinase C and the modulation of G-protein-controlled adenylyl cyclase and other signal transduction systems. In: Sibley DR, Houslay MD (eds). Regulation of Cellular Signal transduction Pathways by Desensitization and Amplification. John wiley and Sons: Chichester, 1994, pp 129-168.
169. Mitchell FM, Griffiths SL, Saggerson ED, Houslay MD, Knowler JT, Milligan G. Guanine-nucleotide-binding proteins expressed in rat white adipose tissue. Identification of both mRNAs and proteins corresponding to Gil, Gi2 and Gi3. Biochem J 1989; 262 (2): 403-408.
170. Kalkbrenner F, Dippel E, Wittig B, Schultz G. Specificity of interaction
171. Doris R, Vernon RG, Houslay MD, Kilgour E. Growth hormone decreases the response to anti-lipolytic agonists and decreases the levels of Gi2 in rat adipocytes. Biochem J 1994; 297: 41-45.
172. Doris RA, Thompson GE, Finley E, Kilgour E, Houslay MD, Vernon RG. Chronic effects of somatotropin treatment on response of subcutaneous adipose tissue lipolysis to acutely acting factors in vivo and in vitro. J Anim Sci 1996; 74: 562-568.
173. Goodman HM, Gorin E, Honeyman TW. Biochemical basis for the lipolytic activity of growth hormone. In: Underwood LE (ed). Human Growth Hormone, Progress and Challenges. Marcel Dekker: New York, 1988, pp 75-111.
174. Borland CA, Barber MC, Travers MT, Vernon RGJ. Growth hormone inhibition of lipogenesis in sheep adipose tissue: requirement for gene transcription and polyamines. J Endocrinol 1994; 142: 235-243.
175. Vernon RGGH. inhibition of lipogenesis and stimulation of lipolysis in sheep adipose tissue: involvement of protein serine phosphorylation and dephosphorylation and phospholipase C. J Endocrinol 1996; 150: 129-140.
176. Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen JO. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol 1994; 266: E211-E216.
177. Ottosson M, Vikman-Adolfsson K, Enerback S, Elander A, Bjorntorp P, Eden S. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1995; 80: 936-941.
178. Rosenbaum M, Gertner JM, Leibel RL. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab 1989; 69: 1274-1281.
179. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999; 23: 260-271.
180. Goh ELK, Zhu T, Yakar S, LeRoith D, Lobie PE. CrkII participation in the cellular effects of growth hormone and insulin like growth factor-1: Phosphatidylinositol-3 kinase dependent and independent effects. J Biol Chem 2000; 275: 17683-17692.